Allworth Financial LP Takes $2.35 Million Position in Ventas, Inc. $VTR

Key Points

• Allworth Financial bought 26,486 Ventas shares worth approximately $2.35 million during the second quarter. Institutional investors collectively own 94.18% of the healthcare REIT.
• Ventas reported quarterly EPS of $0.97, exceeding estimates by $0.01, while revenue reached $1.73 billion and rose 21.7% year over year.
• Analysts maintain a generally positive outlook, with 15 Buy ratings and three Holds, producing a “Moderate Buy” consensus and an average price target of $98.

Allworth Financial LP purchased a new position in Ventas, Inc. (NYSE:VTR - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 26,486 shares of the real estate investment trust's stock, valued at approximately $2,352,000.

Other institutional investors also recently added to or reduced their stakes in the company. Deutsche Bank AG lifted its holdings in Ventas by 0.7% during the fourth quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust's stock worth $302,114,000 after buying an additional 27,688 shares during the period. Bank of New York Mellon Corp boosted its position in Ventas by 2.5% during the 4th quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust's stock valued at $222,000,000 after acquiring an additional 70,459 shares in the last quarter. Norges Bank purchased a new position in shares of Ventas in the 4th quarter valued at $474,571,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of Ventas by 7.4% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,346,111 shares of the real estate investment trust's stock valued at $104,095,000 after acquiring an additional 92,236 shares during the period. Finally, Cbre Investment Management Listed Real Assets LLC raised its position in shares of Ventas by 5.8% in the 4th quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,851,968 shares of the real estate investment trust's stock worth $143,305,000 after acquiring an additional 101,370 shares in the last quarter. Hedge funds and other institutional investors own 94.18% of the company's stock.

Ventas Trading Up 0.7%

Ventas stock opened at $93.32 on Friday. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. Ventas, Inc. has a 12 month low of $66.38 and a 12 month high of $101.60. The stock's 50 day simple moving average is $91.36 and its two-hundred day simple moving average is $87.08. The firm has a market cap of $47.87 billion, a PE ratio of 172.81, a P/E/G ratio of 2.14 and a beta of 0.69.

Ventas (NYSE:VTR - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The business had revenue of $1.73 billion for the quarter, compared to analysts' expectations of $1.68 billion. During the same quarter last year, the company earned $0.87 EPS. The business's revenue was up 21.7% on a year-over-year basis. Analysts anticipate that Ventas, Inc. will post 3.89 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Michael J. Embler acquired 2,500 shares of the firm's stock in a transaction on Wednesday, June 3rd. The stock was acquired at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.53% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on VTR shares. Weiss Ratings upgraded Ventas from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Tuesday, July 21st. UBS Group boosted their target price on shares of Ventas from $85.00 to $93.00 and gave the stock a "neutral" rating in a report on Monday, May 4th. Royal Bank Of Canada raised their price target on shares of Ventas from $98.00 to $99.00 and gave the company an "outperform" rating in a report on Friday, August 14th. JPMorgan Chase & Co. lifted their price objective on shares of Ventas from $93.00 to $94.00 and gave the stock an "overweight" rating in a research report on Monday, May 11th. Finally, Raymond James Financial started coverage on shares of Ventas in a research note on Tuesday, June 16th. They set an "outperform" rating and a $94.00 price objective for the company. Fifteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Ventas has an average rating of "Moderate Buy" and a consensus price target of $98.00.

Ventas Company Profile

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source